DRUG DELIVERY SYSTEMS: VARIATIONS ON DIFFERENT THEMES Newsletter Article 09 February 2013 Pages: 4 - 4
ADVERSE REACTIONS TO BENDROFLUAZIDE AND PROPRANOLOL IN LARGE MAC STUDY Newsletter Article 09 February 2013 Pages: 4 - 5
COAL TAR FOR PSORIASIS — NO INCREASED RISK OF SKIN CANCER Newsletter Article 09 February 2013 Pages: 5 - 5
ENCAINIDE: looks better than quinidine in premature ventricular complexes Newsletter Article 09 February 2013 Pages: 6 - 6
AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED BREAST CANCER Newsletter Article 09 February 2013 Pages: 8 - 9
DOES CONGESTIVE CARDIOMYOPATHY RESPOND TO β-BLOCKADE? Newsletter Article 09 February 2013 Pages: 10 - 10
CHENODEOXYCHOLIC ACID: THE NATIONAL COOPERATIVE GALLSTONE STUDY Newsletter Article 09 February 2013 Pages: 10 - 11
LABETALOL PREVENTS HYPERTENSIVE REBOUND AFTER CLONIDINE WITHDRAWAL Newsletter Article 09 February 2013 Pages: 11 - 11
DEPRESSION: PREVENTION OF RELAPSE BY LITHIUM AND AMITRIPTYLINE Newsletter Article 09 February 2013 Pages: 11 - 12
LIVER DISEASE AFFECTS THE PHARMACOKINETICS OF SEVERAL DRUGS Newsletter Article 09 February 2013 Pages: 13 - 14
THE CLINICAL RELEVANCE OF SOME PHARMACODYNAMIC STUDIES ON CIMETIDINE Newsletter Article 09 February 2013 Pages: 14 - 14
THE PHARMACOKINETICS OF AN EVENING DOSE OF SLOW RELEASE THEOPHYLLINE Newsletter Article 09 February 2013 Pages: 15 - 15
WHEN ARE β-BLOCKERS WITH PARTIAL AGONIST ACTIVITY NEEDED? Newsletter Article 09 February 2013 Pages: 16 - 17
VERAPAMIL IN HYPERTENSION: Update to Issue No. 110 Newsletter Article 09 February 2013 Pages: 20 - 20
VERAPAMIL IN HYPERTROPHIC CARDIOMYOPATHY: Update to Issue No. 110 Newsletter Article 09 February 2013 Pages: 20 - 20